Zantac Lien Resolution

Zantac is the popular brand name of a drug called Ranitidine, a type of medication with histamine-2 blockers, which is widely used to treat various gastrointestinal conditions such as heartburn and acid reflux. Zantac was first sold in the U.S. back in 1983 and quickly became one of the most widely used drugs on the market. On Oct. 18, 2019, manufacturer Sanofi announced a voluntary recall of Zantac due to it containing N-Nitrosodimethylamine (NDMA), which may cause cancer in humans. Potential injuries to people who have used Zantac to treat heartburn may include cancers of the stomach, bladder, kidney, pancreatic, colon, liver, esophagus, lung or breast. Plaintiffs in this litigation have all types of healthcare insurance and all types of healthcare liens may be encountered.